We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

DRG International, Inc.

DRG International, a global innovator of high-quality medical diagnostics and equipment, provides the medical and res... read more Featured Products: More products

Download Mobile App





Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 28 Jul 2015
Print article
The DRG Renin (Active) ELISA Kit
The DRG Renin (Active) ELISA Kit (Photo courtesy of DRG International)
A new ELISA test that measures levels of active renin in human EDTA plasma has been available for inspection at Booth 819 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Measurement of levels of active renin in the blood is useful for diagnosing certain types of hypertension. DRG International (Springfield, NJ, USA) has produced a solid phase "sandwich" ELISA kit that is accurate in the range of 0.8 to 128 picograms per milliliter. The assay uses 50 microliters of EDTA plasma and requires about 3 hours and 15 minutes to perform.

The DRG Renin (Active) ELISA Kit can also effectively detect hypertension in pregnancy. Early discovery of hypertension in the expectant mother opens up a much more effective array of treatment methods for the patient.

“The DRG Renin (Active) ELISA Kit allows research laboratories to quickly and easily measure for renin,” said Dr. Cyril E. Geacintov, founder, president, and CEO of DRG International. “The accuracy of our test has made it the top choice of researchers in the field and its applications continue to grow.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
DRG International


Gold Supplier
INFLUENZA A/B RAPID TEST
COMBO INFLUENZA A+B-CHECK-1
New
Silver Supplier
SARS-CoV-2 RT-PCR Assay
Savvygen SARS-CoV-2 Plus
New
Clinical Chemistry Analyzer
Mispa CXL Pro
New
Silver Supplier
Lipid Profile Analyzer
Cholestech LDX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more

Industry

view channel
Illustration

Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028

The global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.